Farewell to the Scientific Advisory Board

Oliver Ambacher Receives ISAS Prism as Thanks

Dortmund, 17th January 2020

After four terms of office, which lasted from September 1, 2009 to December 31, 2019, Prof. Dr. Stefan Ambacher leaves the Scientific Advisory Board of ISAS. The Scientific Advisory Board of ISAS monitors the ongoing scientific work and advises the Executive Board and the Supervisory Board. Ambacher was Deputy Chairman of this body from March 2010 to December 2018. Ambacher, physicist and professor of power electronics, heads the Fraunhofer Institute of Applied Solid State Physics and teaches at the Institute of Sustainable Technical Systems (INATECH) at the Albert-Ludwigs-University in Freiburg. For his great commitment and the work he has done, Ambacher received an ISAS prism as a sign of gratitude.

Das ISAS bedankt sich bei Prof. Dr. Oliver Stefan Ambacher für sein großes Engagement und die geleistete Arbeit.

ISAS thanks Prof. Dr. Oliver Stefan Ambacher for his great commitment and the work he has done.

Further press releases

13th July 2026

Fabry Disease: a Molecular Map of Lipids in Tissue

A new technique developed at ISAS combines Raman microscopy and mass spectrometry imaging, and it demonstrates that, for the first time, the spatial distribution of lipids can be visualised at cellular and subcellular levels – including further essential information. The new analytical method holds high potential for the diagnosis and treatment of conditions such as Fabry disease, in which molecules undergo local changes within the tissue.

2nd July 2026

Biomedical Image Analysis with AI

Dr Jianxu Chen is taking up a professorship in AI for Biomedical Analysis at the University of Duisburg-Essen. With his research group at ISAS, he is developing AI methods that can be used to comprehensively analyse enormous quantities of complex microscopy images.

29th June 2026

It's What's Inside That Counts: Neutrophils Form Distinct Subtypes

Neutrophils can be divided into two distinct subgroups with completely different functions. The surface protein CD177 plays a decisive role in this. For the first time, researchers from the Faculty of Medicine at the University of Duisburg-Essen and ISAS have been able to demonstrate, using a new integrated proteomics and lipidomics analysis, that the molecular signatures in CD177-defined neutrophils differ significantly from one another. The presence of this surface protein has implications for disease progression, for example in head and neck tumours.

26th November 2025

New Drug Candidates for the Treatment of Heart Failure

Researchers from North Rhine-Westphalia are working on a new therapeutic approach for the treatment of heart failure as part of the recently launched HI-FIVE project. They are developing active substances that specifically inhibit an important enzyme with the aim of closing gaps in the care of patients with heart failure.

26th September 2025

Microbiome Research: EU Network METAMIC 3 Is Looking for Doctoral Candidates

In the new EU network METAMIC 3, young scientists will be researching the role of microbiomes in the context of ‘One Health’ for their dissertations. Metaproteomics methods will be applied in this research. Furthermore, stays at various European institutions are part of the doctoral programme. The doctoral positions are now open for applications.

Prof. Dr. Robert Heyer is Head of the research group Multidimensional Omics Data Analysis at ISAS and coordinator of the network.

7th February 2025

The Less the Better

If neutrophil granulocytes migrate into injured tissue, for example into the brain after a stroke, they can promote chronic inflammation and cause long-term damage. In order to analyze the functional dynamics of these immune cells, millions of them are needed. A group of researchers recently developed a method that enables mass spectrometric analysis with just 1,000 neutrophils.